Document Detail


Therapeutic effects of resveratrol during acute periods following experimental ischemic stroke.
MedLine Citation:
PMID:  20655115     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
We defined whether resveratrol administration during the acute phase of ischemic stroke reduces brain injury in mice. Infarct volumes were decreased significantly in both sexes with different doses of resveratrol (5mg/kg for males and 1mg/kg for females) administered 3h after ischemic stroke. Administration of resveratrol 6h after insult was also effective to decrease infarct volumes. Resveratrol suppressed expressions of IL-1β and TNF-α, microglial activation, and ROS production in the ischemic cortex. The findings suggest that the suppression of inflammation is partly associated with the neuroprotective effects of resveratrol, and resveratrol can be developed as a therapeutic drug for acute ischemic stroke.
Authors:
Jin A Shin; Hyunah Lee; Yoo-Kyoung Lim; Yaekyu Koh; Ji Ha Choi; Eun-Mi Park
Related Documents :
11004415 - Do potential patients prefer tissue plasminogen activator (tpa) over streptokinase (sk)...
18403735 - Meta-analysis of the efficacy of granulocyte-colony stimulating factor in animal models...
17826635 - Extracranial stenosis: endovascular treatment.
15574205 - Early carotid artery stenting and angioplasty in patients with acute ischemic stroke.
7818025 - Left ventricular structure and function by echocardiography in congenital muscular dyst...
2406785 - Splenic infarction: sonographic patterns, diagnosis, follow-up, and complications.
Publication Detail:
Type:  Comparative Study; Journal Article; Research Support, Non-U.S. Gov't     Date:  2010-07-23
Journal Detail:
Title:  Journal of neuroimmunology     Volume:  227     ISSN:  1872-8421     ISO Abbreviation:  J. Neuroimmunol.     Publication Date:  2010 Oct 
Date Detail:
Created Date:  2010-09-20     Completed Date:  2010-10-19     Revised Date:  2013-06-03    
Medline Journal Info:
Nlm Unique ID:  8109498     Medline TA:  J Neuroimmunol     Country:  Netherlands    
Other Details:
Languages:  eng     Pagination:  93-100     Citation Subset:  IM    
Copyright Information:
Copyright © 2010 Elsevier B.V. All rights reserved.
Affiliation:
Department of Pharmacology, Ewha Medical Research Institute, School of Medicine, Ewha Womans University, Seoul, Republic of Korea.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Acute Disease
Animals
Brain Infarction / drug therapy,  immunology,  metabolism
Brain Ischemia / drug therapy*,  immunology,  metabolism
Disease Models, Animal
Dose-Response Relationship, Immunologic
Female
Inflammation Mediators / antagonists & inhibitors,  therapeutic use*
Male
Mice
Mice, Inbred C57BL
Neuroprotective Agents / therapeutic use*
Reactive Oxygen Species / metabolism
Stilbenes / therapeutic use*
Stroke / drug therapy*,  immunology,  metabolism
Chemical
Reg. No./Substance:
0/Inflammation Mediators; 0/Neuroprotective Agents; 0/Reactive Oxygen Species; 0/Stilbenes; Q369O8926L/resveratrol

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Assessing the experience of motherhood: the Being a Mother Scale (BaM-13).
Next Document:  Dominance of E. coli phagocytosis over LPS in the inflammatory response of microglia.